Please login to the form below

Not currently logged in
Email:
Password:

The Havas Life London Award for Customer Focus Excellence via Digital/Social Media

Sponsored by

  • Full Results
    • Winner

      Digital Strategy for the Boehringer Ingelheim Oncology Franchise

      Boehringer Ingelheim in association with infill Kommunikation GmbH


      Finalists

      HBV Casebook

      Gilead Sciences in association with iS Health

      www.allergyeducation.co.uk

      Thermo Fisher Scientific in association with Open LEC


Winner

Digital Strategy for the Boehringer Ingelheim Oncology Franchise

Boehringer Ingelheim in association with infill Kommunikation GmbH


Summary of work

Winner: Boehringer Ingelheim in association with infill Kommunikation GmbH

Boehringer Ingelheim’s (BI) global digital strategy for the oncology franchise is an interconnected and multichannel approach offering quality medical information and education to different target groups, while working under tight legal restrictions for communicating not-yet licensed drugs. Target groups of interest are opinion leaders, healthcare professionals, the media and patients. 

The main components of the strategy are:

  • Intense communication of the global strategy to the regional affiliates
  • GLOW Portal which connects opinion leaders
  • An eNewsletter that connects initiatives quickly with target groups
  • Attractive apps and tools that provide value 
  • Constant SEO, SEM and content updates drive traffic and promote initiatives.
The information communicated to the target groups resulted from feedback from international oncology societies, patient advocacy groups and extensive market research.

All the websites were developed with a CMS (content management system) backend to enable consistency in design, structure and contents used for spinoffs by regional BI affiliates. 

BI’s digital strategy is synergistic and successful in reaching the target audiences, while positioning BI as a trusted name in the world of oncology.

 

 

Executive summary as submitted

Judges comments

"Boehringer Ingelheim’s digital strategy for its oncology franchise was chosen because of the breadth of information available with a high level of consistency to the materials. It took a genuine ecosystem approach that ambitiously addressed multiple stakeholders in a creative and innovative way, offering a useful ability to tailor materials."


Finalists

HBV Casebook - Gilead Sciences in association with iS Health

www.allergyeducation.co.uk - Thermo Fisher Scientific in association with Open LEC